Matches in DBpedia 2016-04 for { <http://doi.org/10.1158/1078-0432.ccr-06-0910> ?p ?o }
Showing triples 1 to 25 of
25
with 100 triples per page.
- 1078-0432.ccr-06-0910 doi "10.1158/1078-0432.CCR-06-0910".
- 1078-0432.ccr-06-0910 first1 "BM".
- 1078-0432.ccr-06-0910 first2 "J".
- 1078-0432.ccr-06-0910 first3 "R".
- 1078-0432.ccr-06-0910 first4 "G".
- 1078-0432.ccr-06-0910 first5 "MS".
- 1078-0432.ccr-06-0910 first6 "A".
- 1078-0432.ccr-06-0910 first7 "CR".
- 1078-0432.ccr-06-0910 first8 "GA".
- 1078-0432.ccr-06-0910 isCitedBy Bivatuzumab_mertansine.
- 1078-0432.ccr-06-0910 issue "20 Pt 1".
- 1078-0432.ccr-06-0910 journal "Clinical cancer research : an official journal of the American Association for Cancer Research".
- 1078-0432.ccr-06-0910 last1 "Tijink".
- 1078-0432.ccr-06-0910 last2 "Buter".
- 1078-0432.ccr-06-0910 last3 "De Bree".
- 1078-0432.ccr-06-0910 last4 "Giaccone".
- 1078-0432.ccr-06-0910 last5 "Lang".
- 1078-0432.ccr-06-0910 last6 "Staab".
- 1078-0432.ccr-06-0910 last7 "Leemans".
- 1078-0432.ccr-06-0910 last8 "Van Dongen".
- 1078-0432.ccr-06-0910 pages "6064–72".
- 1078-0432.ccr-06-0910 pmid "17062682".
- 1078-0432.ccr-06-0910 title "A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus".
- 1078-0432.ccr-06-0910 volume "12".
- 1078-0432.ccr-06-0910 year "2006".